Given the MYC-ZNF148-ID1/3 regulatory axis found in this study, ZNF148 may be involved in the TGF-β downstream pathways, mediating the repression of ID1/3 genes, thus reducing the cancer stem cell properties in breast cancer. The gene discussed is ID1; the disease is cancer.